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Introduction: Acute renal allograft rejection is deﬁne as a sudden
decline in the function of the transplanted kidney that gives rise to
the creatinine levels. Whenever acute rejection is conﬁrmed, the
possibility of inadequate immunosuppression, whether due to
inadequate dosing or noncompliance, must be addressed. The fail-
ure to recognize this contributing factor increases the risk of
continued acute rejection episodes and, due to inadequate long-
term immunosuppression, may eventually lead to graft failure.
However, there is not a pre-deﬁned protocol available to predict the
probability of an adverse event in patients receiving the same
medications. Moreover a more personalized immunosuppressive
therapy may prevent complications and help to avoid graft rejec-
tion. Several Single Nucleotide Polymorphisms (SNPs) have been
already associated with acute renal allograft rejection (AR). There-
fore we aim to identify a pre-operative SNP proﬁle assay that might
underline the differences in the genetic background of the patients.
SNPs are analyzed for allele and genotype frequencies in genes
involved in immune responses and pharmacokinetics/pharmaco-
dynamics of immunosuppressive drugs.
Methods: This is a cohort study. Genomic DNA isolated from 200 ml
of whole blood of 153 kidney transplant patients (42 with AR
(wAR) and 111 without AR (w/oAR)) are genotyped for 20 SNPs in
TNF-alpha, IL-10, ABCB1, UGT1A9, IMPDH2 genes.
Results: The average age of our kidney transplanted patients is 52.8
years and their group consists of 48 females and 105 males. Based on
our preliminary results all SNPs are in Hardy-Weinberg equilib-
rium (HWE) in our study population. No transplant patients wAR
were C/C homozygote for ABCB1 G-2677T/A, T/T and C/C homo-
zygotes for UGT1A9 C-440T and T-331C, respectively. In our
ongoing study so far 9 SNPs have been analyzed by Trend Test
between the two transplanted groups; the p values are above 0.05
for each SNP, with the exception for UGT1A9 C-440T and T-331C
(p ¼ 0.043). The allele frequencies of C for UGT1A9 C-440T and
T for UGT1A9 T-331C are both 70% in the w/oAR group; while, the
allele frequencies of those polymorphisms are increased to 83% in
the wAR group.
Conclusions: The homozygotes T/T and C/C for UGT1A9 C-440T
and T-331C are missing in the wAR group and may deﬁne a possible
protective haplotype for patients w/oAR. However, analyzing the
composition of the two transplant groups there is a statistically
signiﬁcant difference for gender. Thus, to conﬁrm our results a
case-control, multicenter research study is needed. Data from the
newly enrolled patients will allow us to perform an age- and sex-
matched analysis of the patients’ cohort. Understanding the exact
link between these SNPs and acute kidney rejection is crucial to
more successfully maximalize antirejection therapies.S18P39
SHARED AND ENDORGAN SPECIFIC
TRANSCRIPTIONAL NETWORKS IN
SKIN VERSUS KIDNEY BIOPSIES IN
SYSTEMIC LUPUS
Berthier, CC1, Stannard, J2, Myers, EM2, Lowe, L2,
Reed, T2, Davidson, A3, Kretzler, M1, Kahlenberg, MJ2
1University of Michigan, Nephrology, Ann Arbor, USA; 2University of
Michigan, Rheumatology, Ann Arbor, USA; 3Center for Autoimmunity and
Musculoskeletal Diseases, Feinstein Institute for Medical Research, Man-
hasset, USA
Introduction: Skin rash can often herald the onset of a systemic
disease ﬂare in systemic lupus. Further, the subtype of skin lesion
may confer a differential risk of renal involvement. We hypothe-
sized that renal ﬂares may be triggered via a crosstalk between skin
and kidneys and that similar molecular mechanisms may underlie
skin and renal disease. We used systems biology approaches to
integrate the regulatory events occurring speciﬁcally in subacute
cutaneous lupus erythematosus (sCLE) and discoid lupus erythe-
matosus (DLE) and compared with those in LN.
Methods: Formalin-ﬁxed parafﬁn-embedded tissue from 7 normal,
26 DLE and 23 sCLE rash biopsies were analyzed via microarrays.
Gene expression proﬁles from 22 LN (9 WHO III and 13 WHO IV)
and 14 healthy microdissected human renal biopsies (ERCB) were
compared. Genomatix and Ingenuity softwares were used for
downstream analyses.
Results: Analysis of SLE skin lesions. The comparison across DLE
and sCLE vs normal skin identiﬁed a shared network of genes
known to be differentially regulated in systemic lupus (e.g. IFNg,
IL2, IL4, IL6, TLR4). Distinct transcriptional programs were seen
with the regulation of PPAR, B-cell receptor, HIF1a and IL6
signaling highlighted unique to DLE, whereas metabolic and
immune responses predominated in sCLE, with unique ITGB2,
ITGB8, MMP1, TIMP1 expression. Transcriptomic comparison of
SLE skin lesions and lupus nephritis kidneys. Shared transcrip-
tional networks in SLE skin lesions versus LN kidney biopsies
reﬂect similar pathway activation. Respectively 986 and 783
genes were regulated in the same direction in the glomeruli of LN
patients vs controls and in DLE and sCLE vs normal (q-value
<0.05). The 282 genes regulated only in the LN glomeruli and
DLE rashes represented a mainly down- regulated network
highlighting MAPK3, MEP1B, LCK, PPARGC1A, CCL2 and PTEN
as main nodes. Top pathways included PTEN and chemokine
signaling. The 82 genes speciﬁc to LN glomeruli and sCLE showed
a mainly up-regulated network with CD40 as major node.
Ingenuity top pathway was FLT3 signaling in hematopoietic
progenitor cells. FLT3LG is essential in the development and
related processes of dendritic cells, which may play a role in
cutaneous and renal lupus pathogenesis.
Conclusions: DLE and sCLE have overlapping and unique tran-
scriptional expression signatures. Further analysis of these speciﬁc
proﬁles suggests that DLE, which is less associated with renal
involvement, demonstrates repression of inﬂammatory pathways
which could predict protection from renal disease. Contrarily,
sCLE, which is associated with a higher risk of lupus nephritis,
shares overlapping gene regulation involving dendritic cells which
may identify this cellular population as essential to disease devel-
opment for both skin and renal disease. These data may identify
important molecular targets for novel therapies in cutaneous and
renal lupus.Kidney International Reports (2016) 1, S1–S22
